Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance.
- NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_assertion description "[Finally, we have not proved any significant influence of the polymorphisms at positions -2578 C/A and -1154 G/A of the vascular endothelial growth factor gene promoter on the progression of chronic glomerulonephritides even though our study suggests a negative effect of CC genotype of -2578 C/A polymorphism on the clinical course of minimal change disease/focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance.
- NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_assertion evidence source_evidence_literature NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance.
- NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_assertion SIO_000772 21978756 NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance.
- NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_assertion wasDerivedFrom befree-2016 NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance.
- NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_assertion wasGeneratedBy ECO_0000203 NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance.
- befree-2016 importedOn "2016-02-19" NP929003.RAU22kZpzmHgj-PHdXy5dxBDXDiqtkbGMMxr4sF2RiH0w130_provenance.